Lou Cantley
Person
Researcher spearheading work on PI3-kinase inhibitors and their enhanced efficacy with ketogenic diets.
Mentioned in 3 videos
Videos Mentioning Lou Cantley

#30 – Thomas Seyfried, Ph.D.: Controversial discussion—cancer as a mitochondrial metabolic disease?
Peter Attia MD
Mentioned as someone whose research is starting to see the potential applications for metabolic therapies in cancer, known for his work on cellular building blocks.

Dr. Dominic D'Agostino on Developing a Well-Designed Ketogenic Diet and Harnessing Its Benefits
FoundMyFitness
Researcher spearheading work on PI3-kinase inhibitors and their enhanced efficacy with ketogenic diets.

216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.
Peter Attia MD
A researcher who pioneered the PI3-kinase pathway, a key pathway mutated in cancers that drives glucose utilization.